Research Analysts Offer Predictions for QIPT Q2 Earnings

Quipt Home Medical Corp. (NASDAQ:QIPT) – Stifel Canada upped their Q2 2025 earnings per share estimates for shares of Quipt Home Medical in a report released on Tuesday, February 11th. Stifel Canada analyst J. Keywood now expects that the company will post earnings per share of $0.02 for the quarter, up from their previous estimate of $0.01. The consensus estimate for Quipt Home Medical’s current full-year earnings is ($0.05) per share. Stifel Canada also issued estimates for Quipt Home Medical’s Q3 2025 earnings at $0.03 EPS.

Quipt Home Medical (NASDAQ:QIPT) last announced its quarterly earnings data on Monday, February 10th. The company reported ($0.03) earnings per share (EPS) for the quarter. Quipt Home Medical had a negative net margin of 2.66% and a negative return on equity of 6.18%.

Quipt Home Medical Stock Down 1.0 %

NASDAQ QIPT opened at $2.97 on Friday. The stock has a market cap of $127.98 million, a PE ratio of -19.80 and a beta of 0.57. Quipt Home Medical has a 12 month low of $2.30 and a 12 month high of $4.98. The stock’s 50 day moving average is $2.90 and its 200 day moving average is $2.84. The company has a current ratio of 1.20, a quick ratio of 0.86 and a debt-to-equity ratio of 0.73.

Institutional Investors Weigh In On Quipt Home Medical

A number of hedge funds have recently made changes to their positions in the stock. SG Americas Securities LLC purchased a new position in shares of Quipt Home Medical in the third quarter worth about $44,000. Atom Investors LP acquired a new stake in Quipt Home Medical in the third quarter valued at approximately $51,000. XTX Topco Ltd acquired a new stake in Quipt Home Medical in the third quarter valued at approximately $54,000. Wells Fargo & Company MN boosted its stake in shares of Quipt Home Medical by 30.9% in the fourth quarter. Wells Fargo & Company MN now owns 23,851 shares of the company’s stock worth $73,000 after acquiring an additional 5,625 shares during the last quarter. Finally, TD Waterhouse Canada Inc. boosted its stake in shares of Quipt Home Medical by 83.4% in the fourth quarter. TD Waterhouse Canada Inc. now owns 27,435 shares of the company’s stock worth $76,000 after acquiring an additional 12,479 shares during the last quarter. 42.85% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Quipt Home Medical

In other Quipt Home Medical news, VP Patrick Dennis Gamble acquired 17,000 shares of the business’s stock in a transaction on Thursday, December 26th. The shares were bought at an average price of $2.45 per share, with a total value of $41,650.00. Following the transaction, the vice president now directly owns 40,057 shares of the company’s stock, valued at $98,139.65. The trade was a 73.73 % increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at this link. Insiders own 13.40% of the company’s stock.

Quipt Home Medical Company Profile

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.